Microsoft and Adaptive Biotechnologies launch new study to decode immune response to COVID-19

The two firms are expanding their partnership by introducing a new virtual clinical study which will attempt to discover improved diagnostics by observing 1000 participants affected by COVID-19. Read more…
Neowin